Comprehensive Cancer Center Grand Rounds Seminar Series

Wake Forest Baptist Comprehensive Cancer Center's Grand Rounds Seminar Series aims to bring in eminent national and international scientists to speak on topics in the field of cancer research. Seminars are held at 11:30 am on first and/or third Thursdays of the month in Room 10B/10C of the Comprehensive Cancer Center. Please contact Dr. Peiqing Sun to nominate a speaker.

Grand Rounds Seminar Topics

January 4,2018

"From R&D of opioid analgesics with fewer side effects to CIPN in Primates"
Mei-Chuan Ko, PhD
Professor, Department of Physiology & Pharmacology
Wake Forest School of Medicine

January 18, 2018

“The Cancer Data Ecosystem & A Tour of Cancer Data Resources”
Sean Davis, MD, PhD
Center for Cancer Research, National Cancer Institute

February 15, 2018

“Strategies to Identify Women At-Risk for Endometrial Cancer Recurrence”
Russell R. Broaddus, MD, PhD           
Professor, Department of Pathology, Division of Pathology/Lab Medicine
Co-PD/PI, Uterine SPORE
The University of Texas MD Anderson Cancer Center, Houston, TX

March 1, 2018

“Drug costs, affordability, and why it matters in clinical and translational research”
Leonard Saltz, MD
Attending Physician, Gastrointestinal Oncology Service
Executive Director for Value and Sustainability
Memorial Sloan Kettering Cancer Center, NY, NY

March 3, 2018

“Genomics for Precision Cancer Prevention”
Kenneth Offit, MD, MPH
Chief, Clinical Genetics Service
Vice Chairman, Academic Affairs, Department of Medicine,
Co-Leader, Prog in Cancer Survivorship, Outcomes, & Risk
Memorial Sloan-Kettering Cancer Center;
Professor of Medicine and Public Health,
Weill Cornell College of Medicine, Cornell University

April 19, 2018

"Cancer and Aging"
Patricia A. Ganz, MD
Distinguished Professor Health Policy & Management and Medicine
UCLA Fielding School of Public Health
David Geffen School of Medicine at UCLA
Director, Cancer Prevention & Control Research
Jonsson Comprehensive Cancer Center, Los Angeles, CA

May 3, 2018

"Genomics for Precision Cancer Prevention" 
Kenneth Offit, MD, MPH
Chief, Clinical Genetics Service
Vice Chairman, Academic Affairs,
Department of Medicine, Memorial Hospital
Member, Program in Cancer Biology and Genetics
Sloan Kettering institute
Professor of Medicine and Public Health
Weill Cornell Medical College, Cornell University, New York, New York

May 17, 2018

"Identification and Characterization of Transcriptional Enhancers in the Mammalian Genome" 
Bing Ren, PhD
Director, Center for Epigenomics, 
Professor of Cellular and Molecular Medicine
UC San Diego School of Medicine
Member, Ludwig Institute for Cancer Research

June 21, 2018

"Engineering a Bacteria-Based Autonomous Drug Delivery System for Cancer Therapy" 
Bahareh Behkam, PhD
Associate Professor, Mechanical Engineering Department
Core Faculty, School of Biomedical Engineering and Sciences
Affiliate Faculty, Macromolecules Innovation Institute
Virginia Tech Institute for Critical Technology and Applied Sciences 

September 20, 2018

"Searching for Positives in a Land of Negatives"
Kathy D. Miller, MD
Ballve-Lantero Professor
Associate Director for Clinical Research of the IU Melvin and Bren Simon Cancer Center
Indiana University
Co-Chair of the NCI Breast Cancer Steering Committee 

October 4, 2018

"Translating Resistance Mechanisms into Therapeutic Regiments for Melanoma"
Roger S. Lo, MD, PhD
Medicine/Dermatology & Molecular and Medical Pharmacy
Associate Chief, Division of Dermatology
Director, Dermatology STAR Residency Program
Director, Melanoma Clinic in Dermatology
Member, Jonsson Comprehensive Cancer Center
David Geffen School of Medicine at UCLA

November 1, 2018 - CANCELLED

"Marker-guided targeted therapy, PARP inhibitors, and novel post-translational modification of PD-L1"
Mien-Chie Hung, PhD
Vice President, Basic Research
Professor and Chair
Department of Molecular and Cellular Oncology
Distinguished Teaching Professor
Director, Center for Biological Pathways
Director, Breast Cancer Basic Research Program
Ruth Legett Jones Distinguished Chair
University of Texas MD Anderson Cancer Center

November 15, 2018

"Manipulating Tumor Suppressor Networks in Cancer"
Scott W. Lowe, PhD
Investigator, Howard Hughes Medical Institute
Chair, Cancer Biology & Genetics Program,
Memorial Sloan Kettering Cancer Center (MSKCC)
Chair, Geoffrey Beene Cancer Research Center,
Memorial Sloan Kettering Cancer Center (MSKCC)

December 13, 2018

"Gq-RGS Signaling in Diabetes and Pancreatic Cancer"
Thomas M. Wilkie, PhD
Associate Professor, Department of Pharmacology
UT Southwestern Medical Center, Dallas, TX




View the 2017 Grand Round Seminars